ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2023Renaissance Technologies LLCBuy166,100508,773$221,530
Q3 2023Sequoia Financial AdvisorsBuy2664,887$2,127,772
Q3 2023Bill & Melinda Gates Foundation TrustBuy8,5008,500$3,701,070
Q3 2023Sequoia FundBuy101,5731,150,221$500,829,228
Q3 2023Eagle Capital ManagementBuy632,5111,384,478$602,829,411
Q3 2023Brave Warrior AdvisorsBuy306,3261,627,598$708,688,721
Q3 2023First Eagle U.S. ValueSell-22,3641,782,785$776,260,245
Q2 2023Yacktman Asset ManagementBuy1,580388,751$172,718,182
Q2 2023Sound Shore ManagementSell-7,750117,387$52,153,871
Q2 2023Renaissance Technologies LLCBuy170,500342,673$152,246
Q2 2023Vulcan Value PartnersBuy140,817546,818$242,950
Q2 2023Sequoia Financial AdvisorsBuy1144,621$2,052,996
Q2 2023Hancock Classic ValueBuy965192,828$85,671,552
Q2 2023Eagle Capital ManagementSell-47,826751,967$334,091,418
Q2 2023Sequoia FundBuy241,5241,048,648$465,903,820
Q2 2023Brave Warrior AdvisorsBuy236,5041,321,272$587,027,937
Q2 2023Viking Global InvestorsSell-741,8551,412,701$627,648,927
Q2 2023First Eagle U.S. ValueBuy9,5291,805,149$802,009,649
Q1 2023Lountzis Asset ManagementBuy755755$347
Q1 2023Yacktman Asset ManagementBuy471387,171$178,025,098
Q1 2023Renaissance Technologies LLCSell-129,900172,173$79,167
Q1 2023Vulcan Value PartnersBuy92,403406,001$187,131
Q1 2023Sequoia Financial AdvisorsBuy1464,507$2,072,283
Q1 2023Hancock Classic ValueBuy163191,863$88,220,526
Q1 2023Eagle Capital ManagementSell-72,917799,793$367,752,819
Q1 2023Sequoia FundSell-19,399807,124$371,123,687
Q1 2023Brave Warrior AdvisorsBuy212,3531,084,768$498,787,174
Q1 2023First Eagle U.S. ValueBuy5,1191,795,620$825,644,032
Q1 2023Viking Global InvestorsBuy282,3802,154,556$990,686,394
Q4 2022Eagle Capital ManagementSell-434,173872,710$447,674,049

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.